Akums Drugs and Pharmaceuticals Limited is a Delhi-based pharmaceutical contract manufacturer. The company provides solutions for drugs manufacturing research, and development (R&D). Akums Drugs and Pharmaceuticals plans to raise Rs. 680 crore through IPO. The IPO’s fresh issue size is Rs. 680 crore for 10,014,727 shares. The total size of the IPO is Rs 1,856.74 crore for 27,345,162 shares.
Akums Drugs and Pharmaceuticals Limited will open its initial public offerings (IPO) on July 30, 2024 and the IPO offer will stay open until August 1, 2024.
Akums Drugs and Pharmaceuticals Limited IPO has set the price band of ₹646 to ₹679 per share with a lot size of 22 shares.
Table of Contents
![Akums Drugs and Pharmaceuticals Limited IPO GMP Today](https://theinvestadvisory.com/wp-content/uploads/2024/07/Akums-Drugs-and-Pharmaceuticals-IPO-GMP-Price-1024x512.png)
Akums Drugs and Pharmaceuticals Limited Overview
Akums Drugs and Pharmaceuticals is a contractual manufacturer of pharmaceuticals & drugs, also known as the Contract Development and Manufacturing Organization (CDMO). That provide manufacturing, research & development services like pharmaceutical, biotechnology, and medical device production in India and overseas.
Akums Drugs and Pharmaceuticals Limited was founded in 2004. Now it operates many health care & subsidiary companies in India & overseas. Akums Drugs and Pharmaceuticals Ltd primarily focuses on exporting active pharmaceutical ingredients (APIs).
Akums Drugs and Pharmaceuticals IPO Details
IPO Date | July 30, 2024, to August 1, 2024 |
Listing Date | Tuesday, August 6, 2024 |
Face Value | ₹2 per share |
Price Band | ₹646 to ₹679 per share |
Overall Subscriptions | [.] |
Lot Size | 22 Shares |
Total Issue Size | 27,345,162 shares (aggregating up to ₹1,856.74 Cr) |
Fresh Issue | 10,014,727 shares (aggregating up to ₹680.00 Cr) |
Offer for Sale | 17,330,435 shares of ₹2 (aggregating up to ₹1,176.74 Cr) |
Employee Discount | Rs 64 per share |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share holding pre issue | 147,356,280 |
Share holding post issue | 157,371,007 |
Akums Drugs and Pharmaceuticals IPO GMP Today
The last updated Grey Market Premium (GMP) for the Akums Drugs and Pharmaceuticals Limited IPO is ₹269. The estimated listing price for the IPO is between ₹646 to ₹679 per share, combining the cap price with today’s GMP. The following table displays the trend of the Akums Drugs and Pharmaceuticals IPO’s GMP over the past few days.
The expected listing share price range of Akums Drugs and Pharmaceuticals Ltd.’s IPO is ₹679-₹920.
More IPO GMP Lists:-
- S A Tech Software IPO: GMP, Price, Listing Date & Review
- Trom IPO GMP Price Today
- Esprit Stones IPO: GMP, Price, Listing Date & Review
- Bulkcrop International IPO GMP, Price, Date and Review
- Rajputana Industries IPO GMP, Price Date And Review
- Ashapura Logistics IPO: GMP, Price, Date & review
- OLA Electric IPO: GMP, Price, Date and Review
GMP Date | IPO Price | GMP Price |
August 2, 2023 | ₹646-₹679 | ₹270 |
July 30, 2024 | ₹646-₹679 | ₹266 |
July 29, 2024 | ₹646-₹679 | ₹269 |
July 28, 2024 | ₹646-₹679 | ₹255 |
July 27, 2024 | ₹646-₹679 | ₹255 |
July 26, 2024 | ₹646 to ₹679 | ₹250 |
July 25, 2024 | ₹646 to ₹679 | ₹245 |
Akums Drugs and Pharmaceuticals Ltd. IPO: Important Date
All the important dates regarding this IPO are mentioned below. Mark them on your calendar so you don’t miss any events. Akums Drugs and Pharmaceuticals IPO opening date is Wednesday, July 30, 2024 and the offer will open until August 1, 2024.
IPO Open Date | Tuesday, July 30, 2024 |
IPO Close Date | Thursday, August 1, 2024 |
Basis of Allotment | Friday, August 2, 2024 |
Initiation of Refunds | Monday, August 5, 2024 |
Credit of Shares to Demat | Monday, August 5, 2024 |
Listing Date | Tuesday, August 6, 2024 |
Akums Drugs and Pharmaceuticals IPO Lot Size & Investor Types
It offers a minimum of 22 shares per lot. The below table represents the future of minimum and maximum investment for retail investors and HNI concerning shares and amounts.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 22 | ₹14,938 |
Retail (Max) | 13 | 286 | ₹194,194 |
S-HNI (Min) | 14 | 308 | ₹209,132 |
S-HNI (Max) | 66 | 1,452 | ₹985,908 |
B-HNI (Min) | 67 | 1,474 | ₹1,000,846 |
Akums Drugs and Pharmaceuticals IPO Quota
Investor Category | Shares Offered |
---|---|
QIB Shares Offered | Not less than 75.00% of the Net offer |
Retail Shares Offered | Not more than 10.00% of the Offer |
NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
Akums Drugs and Pharmaceuticals IPO Promoter Holdings
Share Holding Pre Issue | 84.94% |
Share Holding Post Issue |
Financial: Income Statement of Akums Drugs and Pharmaceuticals Ltd
Period Ended | FY24 | FY23 | FY22 |
Assets | ₹3,516.37 crore | ₹3,266.53 crore | ₹3,069.05 crore |
Revenue | ₹4,212.21 crore | ₹3,700.93 crore | ₹3,694.52 crore |
Profit After Tax | ₹0.79 crore | ₹97.82 crore | ₹-250.87 crore |
Net Worth | ₹709.50 crore | ₹717.19 crore | ₹621.98 crore |
Reserves and Surplus | ₹861.01 crore | ₹868.70 crore | ₹787.79 crore |
Total Borrowing | ₹491.56 crore | ₹536.97 crore | ₹357.95 crore |
Company Details of Akums Drugs and Pharmaceuticals Limited
304, Mohan Place, LSC Saraswati Vihar, Delhi – 110034
Phone: +91-1169041000
Email: [email protected]
Website: www.akums.in
FAQs
1. What is the Akums Drugs and Pharmaceuticals IPO’s GMP Price?
Today’s GMP price range for Akums Drugs and Pharmaceuticals Ltd.’s IPO is between ₹245 to ₹250.
2. When is the listing date for the Akums Drugs and Pharmaceuticals Limited IPO?
Akums Drugs and Pharmaceuticals IPO’s listing date is Tuesday, August 6, 2024.
3. When is the allotment date for Akums Drugs and Pharmaceuticals IPO’s?
The allotment date of the Akums Drugs and Pharmaceuticals IPO is Friday, August 2, 2024.
4. When will the Akums Drugs and Pharmaceuticals Limited IPO offering date be closed?
Akums Drugs and Pharmaceuticals Limited pre-offering will close on Thursday, August 1, 2024.
Conclusion
Considering all factors, of the company, such as its financial statement, cash flow, debt and revenue, it is clear that the Akums Drugs and Pharmaceuticals Limited IPO will be a good investment for investors. On this webpage, you will receive daily updates related to GMP, date, listing price, and premium discount for the IPO.
To get more information and regular updates on Akums Drugs and Pharmaceuticals Ltd. IPO, keep in touch with The Invest Advisory.